©2019 by Scribe Biosciences.

SCRIBE BIOSCIENCES

Flexible tools for single cell analysis

 

ABOUT US

Scribe Biosciences is an early stage startup borne from a research collaboration between Adam Abate and Zev Gartner's labs at the UCSF to develop robust and scaleable single cell technologies.

Science
 

THE SCRIBE BIOSCIENCES TEAM

Screenshot (8)_edited_edited.png

RUSSELL COLE

CEO & Co-founder

Screenshot (9)_edited_edited.png

MAITHREYAN SRINIVASAN

CSO

Screenshot (10)_edited.png

JUSTIN MADRIGAL

Project scientist

 

WHAT WE DO

Our fundamental technology, Printed Droplet Microfluidics (PDM), is a flexible and reconfigurable fluid handling system to perform picoliter-scale manipulations. By leveraging fluorescence-activated microfluidic droplet sorting and a specialized substrate, PDM enables the flexible and deterministic handling of single cells and fluid aliquots at extremely high throughputs. 

Scribe is currently working under a SBIR research contract from the DARPA INTERCEPT program to adapt PDM technology for single cell virology applications. 

Screenshot (21)_edited.png
 

SPECIAL THANKS TO OUR PARTNERSHIPS

Screenshot (32).png

DARPA

Screenshot (34).png

UCSF

Screenshot (38).png

NATIONAL SOCIETY FOR HISTOTECHLOGY

NSF_4-Color_bitmap_Logo_thumb.jpg

NATIONAL SCIENCE FOUNDATION

 

CONTACT US

953 Indiana St